Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-16

Clinical Trial Update: Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones"

View source ↗

Summary

Clinical trial update on alogliptin tablets in combination therapy with thiazolidinediones for type 2 diabetes mellitus. The study status is completed and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alogliptin (alogliptin)

Snippet

Sponsor: Takeda | Conditions: Type 2 Diabetes Melitus | Status: COMPLETED | Results posted: 2016-09-16